Abgenix Inc., of Fremont, Calif., appointed Marc Better vice president of process sciences.
Abmaxis Inc., of Santa Clara, Calif., appointed C.J. Wang vice president, business development.
Acuity Pharmaceuticals Inc., of Philadelphia, formed a scientific advisory board consisting of Lloyd Aiello, Alexander Brucker, Yihai Cao, Alan Gewirtz, Baruch Kupperman, Richard McCloskey, Lawrence Singerman, William Tasman, Jason Slakter and Lawrence Yannuzzi. The company also added Julia Haller as a clinical consultant and adviser.
Adolor Corp., of Exton, Pa., appointed Richard Woodward vice president, discovery, and promoted George Maurer to vice president, commercial manufacturing.
Aerogen Inc., of Mountain View, Calif., promoted Stacy Pryce to vice president, business development.
Aksys Ltd., of Lincolnshire, Ill., appointed Brian Pereira to its board.
Altus Pharmaceuticals Inc., of Cambridge, Mass., appointed Alan Kimura vice president, clinical development and medical affairs.
Anacor Pharmaceuticals, of Palo Alto, Calif., appointed Richard Markham and Anders Hove to its board.
Anadys Pharmaceuticals Inc., of San Diego, appointed Jennifer Crittenden principal accounting and financial officer.
Argonaut Technologies Inc., of Redwood City, Calif., appointed Lyron Bentovim to its board.
Arriva Pharmaceuticals, of Alameda, Calif., appointed Marvin Garovoy chief medical officer, vice president, clinical development.
AtheroGenics Inc., of Atlanta, appointed Philip Krape senior director, business development, and Robert Small senior director, biostatistics and data management.